Drug
Titanium Dioxide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Madarosis | 11 | 82.5 | 86.4 | signal |
| 2 | Malignant Melanoma | 8 | 52.3 | 54.1 | signal |
| 3 | Basal Cell Carcinoma | 6 | 33.7 | 34.6 | signal |
| 4 | Application Site Erythema | 6 | 20.0 | 20.5 | signal |
| 5 | Application Site Pain | 4 | 15.9 | 16.2 | signal |
| 6 | Acne | 13 | 15.0 | 15.8 | signal |
| 7 | Product Complaint | 3 | 10.5 | 10.7 | signal |